UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 803

Sortiert nach

Paleoenvironmental reconstruction through geochemical analysis of long-lived bivalve shells (Mercenaria stimpsoni)

Fossils, 2022/03/31, Vol.111, pp.5-16

Kubota, Kaoru

2022

Volltextzugriff (PDF)

Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis

Cancer science, 2013-06, Vol.104 (6), p.711-717

2013

Volltextzugriff (PDF)

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

The New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350

2018

Volltextzugriff (PDF)

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-11, Vol.377 (20), p.1919-1929

2017

Volltextzugriff (PDF)

Effect of Communication Skills Training Program for Oncologists Based on Patient Preferences for Communication When Receiving Bad News: A Randomized Controlled Trial

Journal of clinical oncology, 2014-07, Vol.32 (20), p.2166-2172

2014

Volltextzugriff (PDF)

Sediment hardness and water temperature affect the burrowing of Echinocardium cordatum: Implications for mass mortality during the 2011 earthquake–liquefaction–tsunami disaster

Estuarine, coastal and shelf science, 2022-04, Vol.267, p.107763, Article 107763

2022

Volltextzugriff (PDF)

Rapid formation of gigantic spherical dolomite concretion in marine sediments

Sedimentary geology, 2020-07, Vol.404, p.105664, Article 105664

2020

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Journal of thoracic oncology, 2020-06, Vol.15 (6), p.914-947

2020

Volltextzugriff (PDF)

Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE

Journal of clinical oncology, 2022-01, Vol.40 (2), p.180-188

2022

Volltextzugriff (PDF)

Annual shell growth pattern of the Stimpson's hard clam Mercenaria stimpsoni as revealed by sclerochronological and oxygen stable isotope measurements

Palaeogeography, palaeoclimatology, palaeoecology, 2017-01, Vol.465, p.307-315

2017

Volltextzugriff (PDF)

A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC

Cancer, 2022-04, Vol.128 (8), p.1692-1698

2022

Volltextzugriff (PDF)

Equatorial Pacific seawater pCO2 variability since the last glacial period

Scientific reports, 2019-09, Vol.9 (1), p.1-11, Article 13814

2019

Volltextzugriff (PDF)

Rapid decline in pH of coral calcification fluid due to incorporation of anthropogenic CO2

Scientific reports, 2017-08, Vol.7 (1), p.1-9, Article 7694

2017

Volltextzugriff (PDF)

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Journal of clinical oncology, 2012-08, Vol.30 (23), p.2829-2836

2012

Volltextzugriff (PDF)

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Scientific reports, 2018-10, Vol.8 (1), p.14896-9, Article 14896

2018

Volltextzugriff (PDF)

Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

Advances in therapy, 2023-11, Vol.40 (11), p.4928-4944

2023

Volltextzugriff (PDF)

Evaluation of a Tool that Enables Cancer Patients to Participate in the Decision-Making Process during Treatment Selection

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2021-08, Vol.88 (4), p.273

2021

Volltextzugriff (PDF)

Larger CO₂ source at the equatorial Pacific during the last deglaciation

Scientific reports, 2014-06, Vol.4 (1), p.5261-5261, Article 5261

2014

Volltextzugriff (PDF)

Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer

Molecular cancer therapeutics, 2015-11, Vol.14 (11), p.2433-2440

2015

Volltextzugriff (PDF)

Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial

Lung cancer (Amsterdam, Netherlands), 2023-07, Vol.181, p.107195-107195, Article 107195

2023

Volltextzugriff (PDF)

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer

Internal Medicine, 2021/02/15, Vol.60(4), pp.591-594

2021

Volltextzugriff (PDF)

Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma

Internal medicine (Tokyo, 1992), 2023-09, Vol.62 (18), p.2731-2735, Article 1142-22

2023

Volltextzugriff (PDF)

A phase II study of durvalumab (MEDI4736) immediately after completion of chemoradiotherapy in unresectable stage III non–small cell lung cancer: TORG1937 (DATE study)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8536-8536

2022

Volltextzugriff (PDF)

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer

Oncotarget, 2018-06, Vol.9 (43), p.27242-27255

2018

Volltextzugriff (PDF)

1 – 25 von 803

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(763)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(392)
Life Sciences & Biomedicine
(351)
Humans
(294)
Male
(225)
Female
(209)
Oncology
(182)
Aged
(143)
Middle Aged
(133)
Adult
(103)
Lung Neoplasms - Drug Therapy
(100)
Biological And Medical Sciences
(81)
Lung Cancer
(79)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(72)
Lung Neoplasms - Pathology
(72)
Chemotherapy
(69)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(66)
Medical Sciences
(65)
Animals
(63)
Respiratory System
(55)
Treatment Outcome
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Paleoenvironmental reconstruction through geochemical analysis of long-lived bivalve shells (Mercenaria stimpsoni)

Risk factors of chemotherapy‐induced nausea and vomiting: Index for personalized antiemetic prophylaxis

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Effect of Communication Skills Training Program for Oncologists Based on Patient Preferences for Communication When Receiving Bad News: A Randomized Controlled Trial

Sediment hardness and water temperature affect the burrowing of Echinocardium cordatum: Implications for mass mortality during the 2011 earthquake–liquefaction–tsunami disaster

Rapid formation of gigantic spherical dolomite concretion in marine sediments

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE

Annual shell growth pattern of the Stimpson's hard clam Mercenaria stimpsoni as revealed by sclerochronological and oxygen stable isotope measurements

A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC

Equatorial Pacific seawater pCO2 variability since the last glacial period

Rapid decline in pH of coral calcification fluid due to incorporation of anthropogenic CO2

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

Evaluation of a Tool that Enables Cancer Patients to Participate in the Decision-Making Process during Treatment Selection

Larger CO₂ source at the equatorial Pacific during the last deglaciation

Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer

Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer

Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma

A phase II study of durvalumab (MEDI4736) immediately after completion of chemoradiotherapy in unresectable stage III non–small cell lung cancer: TORG1937 (DATE study)

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer

Suchergebnisse filtern